Home β€Ί Stock analysis β€Ί FLNA

Filana Therapeutics (FLNA) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)

Updated Oct 16, 2026, 4:00 PM ET

What changed since yesterday

FLNA slides 7.4% to $0.70, a 1-month low. Closed at $0.70, -7.43% vs the prior close of $0.76. Day range $0.70–$0.76, opened at $0.75.

Last close$0.70-7.43%
Day range0.70–0.76
Open0.75
Volume327.93K
52-week range0.67–4.98
Avg volume (20d)5.84M

FLNA daily analysis β€” what happened

A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.

Oct 16, 2026 β€” FLNA slides 7.4% to $0.70, a 1-month low
Oct 15, 2026 β€” FLNA jumps 4.1% to $0.76
Oct 14, 2026 β€” FLNA dips 1.4% to $0.73, 3 down days in a row
Oct 13, 2026 β€” FLNA slides 3.9% to $0.74
Oct 12, 2026 β€” FLNA slides 6.1% to $0.77
Oct 9, 2026 β€” FLNA rises 1.2% to $0.82
Oct 8, 2026 β€” FLNA dips 1.2% to $0.81, 5 down days in a row
Oct 7, 2026 β€” FLNA slides 5.7% to $0.82, 4 down days in a row
Oct 6, 2026 β€” FLNA ends flat (+0.0%) to $0.87, 3 down days in a row
Oct 5, 2026 β€” FLNA slides 6.5% to $0.87
Oct 2, 2026 β€” FLNA slides 4.1% to $0.93

FLNA latest news & SEC filings

Every SEC filing by or about FLNA in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.

Oct 1, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.

Source: SEC EDGAR filing 0001437749-26-031654

Sep 30, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.

Source: SEC EDGAR filing 0001437749-26-031597

Sep 22, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001171843-26-006161

Sep 18, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001437749-26-030751

Jul 29, 2026 Β· Form 10-Q β€” Quarterly report

Quarterly report (unaudited financial statements for the quarter)

Key figures from this report aren't in the SEC's structured data yet (usually appears within a day or two).

Source: SEC EDGAR filing 0001437749-26-024752

Jul 29, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

This is a results-day filing: the earnings press release is attached as an exhibit.

Source: SEC EDGAR filing 0001171843-26-004982

Things to know before you trade FLNA

FLNA market data (last 20 sessions)

DateOpenHighLowCloseVolume
Oct 16, 20260.750.760.700.70327.93K
Oct 15, 20260.710.770.700.76248.50K
Oct 14, 20260.730.740.720.73253.20K
Oct 13, 20260.760.770.740.74323.50K
Oct 12, 20260.810.810.760.77360.40K
Oct 9, 20260.820.840.800.82407.90K
Oct 8, 20260.800.820.780.81610.80K
Oct 7, 20260.850.850.790.82759.20K
Oct 6, 20260.890.900.830.87670.00K
Oct 5, 20260.920.930.870.871.03M
Oct 2, 20260.971.040.930.931.69M
Oct 1, 20261.001.030.930.972.80M
Sep 30, 20260.930.950.860.89769.50K
Sep 29, 20260.850.940.830.921.20M
Sep 28, 20260.730.890.720.852.05M
Sep 25, 20260.780.780.740.75771.90K
Sep 24, 20260.850.900.740.772.31M
Sep 23, 20261.001.000.800.875.47M
Sep 22, 20260.981.300.901.0394.30M
Sep 21, 20260.740.770.730.74336.50K

About Filana Therapeutics

Filana Therapeutics (FLNA) is listed on the Nasdaq and classified by the SEC under β€œPharmaceutical Preparations”. Its business address is in AUSTIN, TX. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1069530.

FLNA board of directors & executives

From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).

Directors

NameRoleLatest filing
Robert Eugene Jr AndersonDirectorNov 25, 2025
Richard BarryPresident & CEOSep 30, 2026
Dawn Carter BirDirectorOct 22, 2025

Executive officers

NameTitleLatest filing
Richard BarryPresident & CEOSep 30, 2026
Robert Christopher CookChief Operating & Legal OfficeOct 2, 2025

Recent insider buys & sales

DateInsiderTypeSharesPrice
Sep 28, 2026Richard BarryBuy93,091$0.84
Sep 28, 2026Richard BarryBuy93,091$0.84
Sep 28, 2026Richard BarryBuy93,091$0.84
Sep 28, 2026Richard BarryBuy93,091$0.84
Nov 24, 2025Robert Eugene Jr AndersonBuy8,600$2.90
Nov 24, 2025Robert Eugene Jr AndersonBuy8,600$2.90
Nov 24, 2025Robert Eugene Jr AndersonBuy8,600$2.90
Nov 24, 2025Robert Eugene Jr AndersonBuy8,600$2.90
Nov 20, 2025Richard BarryBuy150,000$2.76
Nov 20, 2025Richard BarryBuy150,000$2.76
Nov 20, 2025Richard BarryBuy150,000$2.76
Nov 20, 2025Richard BarryBuy150,000$2.76
Nov 19, 2025Richard BarryBuy73,385$2.75
Nov 19, 2025Richard BarryBuy73,385$2.75
Nov 19, 2025Richard BarryBuy73,385$2.75

FLNA financials (annual, from XBRL filings)

Fiscal year endRevenueNet incomeDiluted EPSOperating cash flow
Dec 31, 2025β€”$-90.97M-1.88$-32.25M
Dec 31, 2024β€”$-24.34M-1.46$-116.93M
Dec 31, 2023β€”$-97.22M-2.32$-82.03M
Dec 31, 2022β€”$-76.25M-1.90$-77.51M
Dec 31, 2021β€”$-32.38Mβ€”$-30.20M

Latest balance sheet: total assets $108.37M, total liabilities $40.23M, cash $86.57M (as of Mar 31, 2026).

FLNA earnings / results-day log

DateFilingClose that day
Jul 29, 20268-K Item 2.02 (results)$0.87
May 7, 20268-K Item 2.02 (results)$1.36
Mar 12, 20268-K Item 2.02 (results)$1.95
Nov 12, 20258-K Item 2.02 (results)$3.26
Aug 14, 20258-K Item 2.02 (results)$2.41
May 8, 20258-K Item 2.02 (results)$1.70
Mar 3, 20258-K Item 2.02 (results)$2.48
Jan 7, 20258-K Item 2.02 (results)$3.02
Nov 7, 20248-K Item 2.02 (results)$25.34
Aug 8, 20248-K Item 2.02 (results)β€”
May 10, 20248-K Item 2.02 (results)β€”
Feb 28, 20248-K Item 2.02 (results)β€”

Related stocks Β· Pharmaceutical Preparations

Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)

Popular today

Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)

More on FLNA

Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.